/PRNewswire/ Based on a recent industry assessment of the precision health informatics market, Frost & Sullivan recognizes LifeOmic with the 2021 North.
Share this article
Share this article
With scalable, advanced resource and technology capabilities, Tergus presents pharma companies with exceptional CRO services for all their drug discovery and development requirements
SANTA CLARA, Calif., March 8, 2021 /PRNewswire/ Based on its recent analysis of the North American contract research organization (CRO) market in dermatology, Frost & Sullivan recognizes Tergus Pharma (Tergus) with the 2020 North America Customer Value Leadership Award. It has continually built on technical, professional, and structural capabilities to deliver a functional service provider-like model that addresses specialty pharma s needs in topical drug discovery and development programs. Its customer-centric, flexible, and tailored services deliver a real partner-level engagement, regardless of project size.